EIS KNUT

No ORCID on file · 17 papers in corpus · active 2008
2008
New sulfoximine-substituted quinoline and/or quinazoline derivatives are erythropoietin-producing hepatoma amplified sequence-receptor kinase inhibitors useful to prepare medicaments to e.g. treat endometriosis and stenosis

Sulfoximine-substituted quinoline and/or quinazoline derivatives (I) and their N-oxides, solvates, hydrates, stereoisomers, diastereoisomers, enantiomers and salts are new. Sulfoximine-substituted quinoline and/or quinazoline derivatives of…

2008
New sulfoximine-substituted quinoline and/or quinazoline derivatives are erythropoietin-producing hepatoma amplified sequence-receptor kinase inhibitors useful to prepare medicaments to e.g. treat endometriosis and stenosis

Sulfoximine-substituted quinoline and/or quinazoline derivatives (I) and their N-oxides, solvates, hydrates, stereoisomers, diastereoisomers, enantiomers and salts are new. Sulfoximine-substituted quinoline and/or quinazoline derivatives of…

2008
New sulfoximine-substituted quinoline and/or quinazoline derivatives are erythropoietin-producing hepatoma amplified sequence-receptor kinase inhibitors useful to prepare medicaments to e.g. treat endometriosis and stenosis

Sulfoximine-substituted quinoline and/or quinazoline derivatives (I) and their N-oxides, solvates, hydrates, stereoisomers, diastereoisomers, enantiomers and salts are new. Sulfoximine-substituted quinoline and/or quinazoline derivatives of…

2008
New sulfoximine-substituted quinoline and/or quinazoline derivatives are erythropoietin-producing hepatoma amplified sequence-receptor kinase inhibitors useful to prepare medicaments to e.g. treat endometriosis and stenosis

Sulfoximine-substituted quinoline and/or quinazoline derivatives (I) and their N-oxides, solvates, hydrates, stereoisomers, diastereoisomers, enantiomers and salts are new. Sulfoximine-substituted quinoline and/or quinazoline derivatives of…

2008
New sulfoximine-substituted quinoline and/or quinazoline derivatives are erythropoietin-producing hepatoma amplified sequence-receptor kinase inhibitors useful to prepare medicaments to e.g. treat endometriosis and stenosis

Sulfoximine-substituted quinoline and/or quinazoline derivatives (I) and their N-oxides, solvates, hydrates, stereoisomers, diastereoisomers, enantiomers and salts are new. Sulfoximine-substituted quinoline and/or quinazoline derivatives of…

2008
New sulfoximine-substituted quinoline and/or quinazoline derivatives are erythropoietin-producing hepatoma amplified sequence-receptor kinase inhibitors useful to prepare medicaments to e.g. treat endometriosis and stenosis

Sulfoximine-substituted quinoline and/or quinazoline derivatives (I) and their N-oxides, solvates, hydrates, stereoisomers, diastereoisomers, enantiomers and salts are new. Sulfoximine-substituted quinoline and/or quinazoline derivatives of…

2008
New sulfoximine-substituted quinoline and/or quinazoline derivatives are erythropoietin-producing hepatoma amplified sequence-receptor kinase inhibitors useful to prepare medicaments to e.g. treat endometriosis and stenosis

Sulfoximine-substituted quinoline and/or quinazoline derivatives (I) and their N-oxides, solvates, hydrates, stereoisomers, diastereoisomers, enantiomers and salts are new. Sulfoximine-substituted quinoline and/or quinazoline derivatives of…

2008
New sulfoximine-substituted quinoline and/or quinazoline derivatives are erythropoietin-producing hepatoma amplified sequence-receptor kinase inhibitors useful to prepare medicaments to e.g. treat endometriosis and stenosis

Sulfoximine-substituted quinoline and/or quinazoline derivatives (I) and their N-oxides, solvates, hydrates, stereoisomers, diastereoisomers, enantiomers and salts are new. Sulfoximine-substituted quinoline and/or quinazoline derivatives of…

2008
New sulfoximine-substituted quinoline and/or quinazoline derivatives are erythropoietin-producing hepatoma amplified sequence-receptor kinase inhibitors useful to prepare medicaments to e.g. treat endometriosis and stenosis

Sulfoximine-substituted quinoline and/or quinazoline derivatives (I) and their N-oxides, solvates, hydrates, stereoisomers, diastereoisomers, enantiomers and salts are new. Sulfoximine-substituted quinoline and/or quinazoline derivatives of…

2008
New sulfoximine-substituted quinoline and/or quinazoline derivatives are erythropoietin-producing hepatoma amplified sequence-receptor kinase inhibitors useful to prepare medicaments to e.g. treat endometriosis and stenosis

Sulfoximine-substituted quinoline and/or quinazoline derivatives (I) and their N-oxides, solvates, hydrates, stereoisomers, diastereoisomers, enantiomers and salts are new. Sulfoximine-substituted quinoline and/or quinazoline derivatives of…

2008
New sulfoximine-substituted quinoline and/or quinazoline derivatives are erythropoietin-producing hepatoma amplified sequence-receptor kinase inhibitors useful to prepare medicaments to e.g. treat endometriosis and stenosis

Sulfoximine-substituted quinoline and/or quinazoline derivatives (I) and their N-oxides, solvates, hydrates, stereoisomers, diastereoisomers, enantiomers and salts are new. Sulfoximine-substituted quinoline and/or quinazoline derivatives of…

2008
New sulfoximine-substituted quinoline and/or quinazoline derivatives are erythropoietin-producing hepatoma amplified sequence-receptor kinase inhibitors useful to prepare medicaments to e.g. treat endometriosis and stenosis

Sulfoximine-substituted quinoline and/or quinazoline derivatives (I) and their N-oxides, solvates, hydrates, stereoisomers, diastereoisomers, enantiomers and salts are new. Sulfoximine-substituted quinoline and/or quinazoline derivatives of…

2008
New sulfoximine-substituted quinoline and/or quinazoline derivatives are erythropoietin-producing hepatoma amplified sequence-receptor kinase inhibitors useful to prepare medicaments to e.g. treat endometriosis and stenosis

Sulfoximine-substituted quinoline and/or quinazoline derivatives (I) and their N-oxides, solvates, hydrates, stereoisomers, diastereoisomers, enantiomers and salts are new. Sulfoximine-substituted quinoline and/or quinazoline derivatives of…

2008
New sulfoximine-substituted quinoline and/or quinazoline derivatives are erythropoietin-producing hepatoma amplified sequence-receptor kinase inhibitors useful to prepare medicaments to e.g. treat endometriosis and stenosis

Sulfoximine-substituted quinoline and/or quinazoline derivatives (I) and their N-oxides, solvates, hydrates, stereoisomers, diastereoisomers, enantiomers and salts are new. Sulfoximine-substituted quinoline and/or quinazoline derivatives of…

2008
New sulfoximine-substituted quinoline and/or quinazoline derivatives are erythropoietin-producing hepatoma amplified sequence-receptor kinase inhibitors useful to prepare medicaments to e.g. treat endometriosis and stenosis

Sulfoximine-substituted quinoline and/or quinazoline derivatives (I) and their N-oxides, solvates, hydrates, stereoisomers, diastereoisomers, enantiomers and salts are new. Sulfoximine-substituted quinoline and/or quinazoline derivatives of…

2008
New sulfoximine-substituted quinoline and/or quinazoline derivatives are erythropoietin-producing hepatoma amplified sequence-receptor kinase inhibitors useful to prepare medicaments to e.g. treat endometriosis and stenosis

Sulfoximine-substituted quinoline and/or quinazoline derivatives (I) and their N-oxides, solvates, hydrates, stereoisomers, diastereoisomers, enantiomers and salts are new. Sulfoximine-substituted quinoline and/or quinazoline derivatives of…

2008
New sulfoximine-substituted quinoline and/or quinazoline derivatives are erythropoietin-producing hepatoma amplified sequence-receptor kinase inhibitors useful to prepare medicaments to e.g. treat endometriosis and stenosis

Sulfoximine-substituted quinoline and/or quinazoline derivatives (I) and their N-oxides, solvates, hydrates, stereoisomers, diastereoisomers, enantiomers and salts are new. Sulfoximine-substituted quinoline and/or quinazoline derivatives of…